Silverarc Capital Management »

Sagimet Biosciences Inc-a shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $880k 100k 8.80

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Sagimet Biosciences Inc-a

NEA Management Company
Baker Bros. Advisors
Hillhouse Capital Advisors
Artal Group
Partner Fund Management
Alyeska Investment Group
Blue Owl Capital Holdings
Vanguard Group
Dumac
AlphaCentric Advisors
Federated Investors
Bank of New York Mellon
Victory Capital Management
Millennium Management
Two Sigma Investments

View all funds holding Sagimet Biosciences Inc-a